Ola Electric, Mankind Pharma among top losers on Nifty Midcap 150

Shares of several companies experienced declines in today's trading session, positioning them among the top losers on the Nifty Midcap 150 index. Ola Electric's stock declines 2%, taking a u-turn after a positive open. Shares of Mankind Pharma shares also declined nearly 2%. IDFC First Bank and Ashok Leyland were also among the notable losers on the index.

Mankind Pharma Ltd's board is scheduled to convene on July 31, 2025, to consider and potentially approve the unaudited standalone and consolidated financial results for the quarter ending June 30, 2025. The board will also evaluate the declaration of an interim dividend, if any, for the financial year 2025-26.

Mankind Pharma Financial Overview:

The following table presents the financial performance of Mankind Pharma, offering insights into its revenue, net profit, and EPS over the recent quarters:

The company's revenue has shown a fluctuating pattern over the quarters, with a general upward trend. Net profit also saw variations, reflecting the dynamic nature of the pharmaceutical industry. The yearly consolidated financial performance shows consistent growth. Revenue increased from Rs 6,214.43 Crore in 2021 to Rs 12,207.44 Crore in 2025. Net profit also rose from Rs 1,281.36 Crore in 2021 to Rs 1,998.88 Crore in 2025. Earnings per share (EPS) have increased from Rs 31.59 in 2021 to Rs 49.28 in 2025.IDFC First Bank Financial Highlights:

IDFC First Bank's financial performance shows the following trends in key metrics:

The quarterly results indicate fluctuating revenues and net profits, reflecting the challenges and opportunities in the banking sector. The yearly financial performance of IDFC First Bank presents a long-term perspective on its growth and profitability. The interest earned has increased from Rs 15,968 Crore in 2021 to Rs 36,501 Crore in 2025. The net profit has seen a significant turnaround, from a loss of Rs 483 Crore in 2021 to a profit of Rs 1,490 Crore in 2025.Ashok Leyland Financial Performance:

The quarterly results of Ashok Leyland show the following trends:

The consolidated yearly financial performance indicates a growing trajectory. The sales have increased from Rs 19,454 Crore in 2021 to Rs 48,535 Crore in 2025. Net profit has also increased from -69 Crore in 2021 to Rs 3,351 Crore in 2025.
The company has announced a bonus issue with a record date of July 16, 2025, offering a 1:1 bonus ratio.

NMDC Financial Performance:

NMDC's quarterly results reflect the following financial metrics:

The yearly results of NMDC show an increasing trend in revenue and net profit over the years. The revenue has increased from Rs 15,370.06 Crore in 2021 to Rs 23,905.52 Crore in 2025. Similarly, the net profit has risen from Rs 6,247.07 Crore in 2021 to Rs 6,538.82 Crore in 2025.
NMDC announced an interim dividend of Rs 2.30 per share, with the ex-date set for March 21, 2025.

Several stocks experienced declines during today's trading session, positioning them among the top losers on the Nifty Midcap 150, with Ola Electric, Mankind Pharma, IDFC First Bank, Ashok Leyland, and NMDC being particularly affected.